Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

Name: Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)
Published: 2010
License: Public Domain

Novartis Pharmaceuticals · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

colchicine resistant/intolerant familial mediterranean fever, fmf, colchicine resistant, colchicine intolerant, flare rate, canakinumab, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)

Related documents